Company Legal Name
Latest Valuation
Founded Year
Headquarter
Medlinker operates a healthcare software platform that connects doctors, patients, and clinics across China, specializing in chronic disease management solutions. Founded in 2014 and headquartered in Chengdu, the company addresses China's growing healthcare digitization needs by facilitating medical consultations and care coordination through its integrated technology platform. As Chengdu Medical Cloud Technology Co., Ltd., Medlinker has positioned itself within China's expanding telemedicine market, leveraging the country's increasing adoption of digital health services and aging population demographics. The company continues to focus on enhancing its platform capabilities and expanding its network of healthcare providers to serve China's chronic disease patient population.
Revenue & Revenue Growth Share
Revenue
Revenue Growth
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.





